Page 20 - Central Drug Authority Annual Report 2021
P. 20
3.3 Substance Use and Abuse, and COVID-19-Related
Distress
5HVHDUFK VKRZV WKDW WKHUH KDV EHHQ D VXEVWDQWLDO LQFUHDVH LQ 7KH DERYH DOVR FDOOV LQWR VKDUSHU IRFXV WKH QHHG IRU DQ
VXEVWDQFH XVH DQG DEXVH GXULQJ WKH &29,' SDQGHPLF DQG LQWHJUDWHG DQG KROLVWLF DSSURDFK LQ DGGUHVVLQJ WKH FKDOOHQJ-
WKDW VXEVWDQFH XVH DEXVH LV D FRPPRQO\ UHSRUWHG ZD\ RI HV RI VXEVWDQFH DEXVH EXW DOVR WKH QHJDWLYH LPSDFW EURXJKW
FRSLQJ ZLWK DQ[LHW\ FRQFHUQLQJ &29,' WR EHDU E\ WKH SDQGHPLF
$Q[LHW\ DERXW &29,' LV PRUH WKDQ VLPSO\ ZRUU\LQJ DERXW
LQIHFWLRQ 5HVHDUFK SURYLGHV HYLGHQFH RI D &29,' 6WUHVV 3.4 Risk of Higher Levels of Alcohol Induced GBV
6\QGURPH FKDUDFWHUL]HG E\
D :RUU\ DERXW WKH GDQJHUV RI &29,' DQG ZRUU\ DERXW :LWK ORFNGRZQ PHDVXUHV DQG ZLGHVSUHDG RUJDQLVDWLRQDO
FRPLQJ LQWR FRQWDFW ZLWK FRURQDYLUXV FRQWDPLQDWHG FORVXUHV UHODWHG WR &29,' OLNHO\ WR FRQWLQXH IRU DQ
REMHFWV RU VXUIDFHV H[WHQGHG SHULRG RI WLPH VWUHVV DQG DVVRFLDWHG ULVN IDFWRUV IRU
E :RUU\ DERXW WKH SHUVRQDO VRFLRHFRQRPLF LPSDFW RI IDPLO\ YLROHQFH VXFK DV XQHPSOR\PHQW UHGXFHG LQFRPH
&29,' OLPLWHG UHVRXUFHV DQG OLPLWHG VRFLDO VXSSRUW DUH OLNHO\ WR EH
F ;HQRSKRELF ZRUULHV WKDW IRUHLJQHUV DUH VSUHDGLQJ FRPSRXQGHG IXUWKHU
&29,'
G &29,' UHODWHG WUDXPDWLF VWUHVV V\PSWRPV H J $GGLWLRQDOO\ DOFRKRO DEXVH D FRPPRQO\ UHSRUWHG ULVN IDFWRU
QLJKWPDUHV IRU IDPLO\ YLROHQFH KDV EHHQ OLQNHG WR DQ DFFXPXODWLRQ RI
H &RQFHUQ DERXW WKH VDIHW\ RI VHOI DQG ORYHG RQHV VWUHVVIXO HYHQWV DQG D ODFN RI VRFLDO VXSSRUW ERWK OLNHO\
I *ULHI DQ[LHW\ DQG RWKHU PHQWDO KHDOWK LVVXHV DULVLQJ RFFXUULQJ DV D UHVXOW RI &29,' :LWK EDUV DQG UHVWDXUDQWV
RXW RI WKH GHDWK RI IDPLO\ PHPEHUV DQG VLJQLˉFDQW EHLQJ OLPLWHG WR WDNH RXW VHUYLFHV RQO\ DW FHUWDLQ ORFNGRZQ
RWKHUV DQG OHYHOV LQ 6RXWK $IULFD IDPLO\ YLROHQFH SHUSHWUDWRUV ZKR
J &29,' UHODWHG FRPSXOVLYH FKHFNLQJ DQG DEXVH DOFRKRO LQ PDQ\ FRPPXQLWLHV PD\ HYHQ EH PRUH OLNHO\
UHDVVXUDQFH VHHNLQJ WR GR VR LQ WKH KRPH LQFUHDVLQJ WKH ULVN IRU WKH HQWLUH
5HVHDUFK DOVR SURYLGHV HYLGHQFH RI DQRWKHU FRQVWHOODWLRQ RU KRXVHKROG $Q LQFUHDVLQJ ULVN RI GRPHVWLF YLROHQFH UHODWHG
ȢV\QGURPHȣ FKDUDFWHUL]HG E\ KRPLFLGH LV DOVR D JURZLQJ FRQFHUQ DV UHSRUWV FRQWLQXH WR
VXUIDFH DURXQG WKH JOREH RI LQWLPDWH SDUWQHU KRPLFLGHV ZLWK
WLHV WR VWUHVV RU RWKHU IDFWRUV UHODWHG WR WKH &29,'
D %HOLHI WKDW RQH KDV UREXVW SK\VLFDO KHDOWK DJDLQVW
&29,' SDQGHPLF $QGUHZ 0 &DPSEHOO
E %HOLHI WKDW WKH WKUHDW RI &29,' KDV EHHQ
H[DJJHUDWHG $OO WKH VWXGLHV LQGLFDWHG DERYH LOOXVWUDWH WKH QHJDWLYH LPSDFW
F 'LVUHJDUG IRU VRFLDO GLVWDQFLQJ ZHDULQJ PDVNV DQG &29,' KDV KDG RQ VRFLHW\ 7KRXJK WKH VWXGLHV DUH VWLOO
RWKHU &29,' SURWRFROV RQJRLQJ ZH KDYH VHHQ DQ XSVXUJH LQ 6RXWK $IULFD ZKHQ
DOFRKRO UHVWULFWLRQV DUH OLIWHG FRPSDUHG WR ZKHQ WKH\ DUH LQ
IRUFH 7KHUH LV D GLUH QHHG IRU UHVHDUFK LQ WKH FRXQWU\ VR WKDW
7KHVH DOVR IRUP D QHWZRUN RI QRGHV NQRZQ DV &29,' WKH EURDGHU LPSDFW RI VXEVWDQFH DEXVH LQ WKH FRQWH[W RI
'LVUHJDUG 6\QGURPH DQG GUXJ DEXVH $EVWUDFW 6XEVWDQFH &29,' RQ LQGLYLGXDOV WKH IDPLO\ DQG HQWLUH FRPPXQLWLHV
8VH DQG $EXVH &29,' 5HODWHG 'LVWUHVV
PD\ EH LQWHJUDWHG LQWR LQWHUYHQWLRQ HIIRUWV DQG UHVSRQVHV
7KH QHHG WR DGGUHVV PHQWDO KHDOWK FKDOOHQJHV IRU XVHUV RI
7KH SUHVHQW VWXGLHV WKDW ZHUH FRQGXFWHG EDVHG RQ D SRSXOD- VXEVWDQFHV WKRVH ZLWK VXEVWDQFH XVH GLVRUGHUV DQG WKRVH
WLRQ UHSUHVHQWDWLYH VDPSOH RI $PHULFDQ DQG &DQDGLDQ DIIHFWHG E\ VXEVWDQFH DEXVH QHHGV WR EH JLYHQ XUJHQW
DGXOWV VRXJKW WR LQYHVWLJDWH KRZ WKHVH &29,' V\QGURPHV priority.
DUH UHODWHG WR VXEVWDQFH XVH DQG DEXVH ,W ZDV IRXQG WKDW
WKHUH ZDV VXEVWDQWLDO HYLGHQFH WR VXJJHVW WKDW ZKHUH WKHVH
V\QGURPHV SUHYDLOHG WKHUH ZDV D FRQFRPLWDQW LQFUHDVH LQ
DOFRKRO DQG GUXJ XVH UHODWHG SDWWHUQV 1HWZRUN DQDO\VHV
LQGLFDWHG WKDW DOWKRXJK WKH WZR V\QGURPHV &29,' 6WUHVV
6\QGURPH DQG &29,' 'LVUHJDUG 6\QGURPH DUH QHJDWLYHO\
FRUUHODWHG ZLWK RQH DQRWKHU ERWK KDYH SRVLWLYH OLQNV WR
LQFUHDVHG DOFRKRO DQG GUXJ DEXVH $EVWUDFW 6XEVWDQFH 8VH
DQG $EXVH &29,' 5HODWHG 'LVWUHVV
18 Annual Report 2020/2021 Central Drug Authority